Expertise in
4
conditions

Lawrence M. Cher

145 Studley Road, 
Heidelberg, VIC, AU 
Expertise in
4
conditions
145 Studley Road, 
Heidelberg, VIC, AU 

Overview

Lawrence Cher practices practicing medicine in Heidelberg, Australia.

Mr. Cher is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Gliomatosis Cerebri.

He is actively involved in clinical research, co-authoring 39 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

145 Studley Road, Heidelberg, VIC 3084, Australia
Other Locations
Studley Road, Heidelberg, VIC 3084, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 1b, Open-Label, Safety and Tolerability Study of TTAC-0001 in Combination With Pembrolizumab in Patients With Recurrent Glioblastoma
A Phase 1b, Open-Label, Safety and Tolerability Study of TTAC-0001 in Combination With Pembrolizumab in Patients With Recurrent Glioblastoma
Enrollment Status: Unknown
Publish Date: August 17, 2022
Intervention Type: Drug
Study Drug: TTAC-0001+Pembrolizumab
Study Phase: Phase 1
IDH Mutated 1p/19q Intact Lower Grade Glioma Following Resection: Wait Or Treat? IWOT - a Phase III Study
IDH Mutated 1p/19q Intact Lower Grade Glioma Following Resection: Wait Or Treat? IWOT - a Phase III Study
Enrollment Status: Terminated
Publish Date: February 01, 2022
Intervention Type: Radiation, Drug, Procedure
Study Drug: Temozolomide
Study Phase: Phase 3
View 1 Less Clinical Trial

39 Total Publications

Monitoring glioblastoma dynamics during chemoradiation on the 1.5 T magnetic resonance imaging-linear accelerator.
Monitoring glioblastoma dynamics during chemoradiation on the 1.5 T magnetic resonance imaging-linear accelerator.
Journal: Clinical and translational radiation oncology
Published: May 22, 2026

Frequently Asked Questions about Lawrence M. Cher

Is Lawrence M. Cher a top-rated expert for Glioblastoma?

MediFind is an objective health platform that identifies experts based on real-world data. Lawrence M. Cher is classified as an Distinguished expert for Glioblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Lawrence M. Cher participate in research or clinical trials?

Yes. Lawrence M. Cher has published 39 articles and abstracts on conditions like Glioblastoma. You can view a list of Lawrence M. Cher's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Cher's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile